Paragon Capital Management LTD Abb Vie Inc. Transaction History

Paragon Capital Management LTD

$487 Million
Q3 2024

A detailed history of Paragon Capital Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Paragon Capital Management LTD holds 7,559 shares of ABBV stock, worth $1.36 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

7,559

Previous 7,829 3.45%

Holding current value

$1.36 Million

Previous $1.34 Million 11.18%

% of portfolio

0.31%

Previous 0.25%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $44,236 - $53,819	-270 Reduced 3.45%	7,559 $1.49 Million
Q2 2024 Jul 12, 2024	SELL	$154.79 - $180.76 $14,550 - $16,991	-94 Reduced 1.19%	7,829 $1.34 Million
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $70,800 - $80,670	-443 Reduced 5.3%	7,923 $1.44 Million
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $4,678 - $5,268	-34 Reduced 0.4%	8,366 $1.3 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $667 - $773	5 Added 0.06%	8,400 $1.25 Million
Q2 2023 Jul 11, 2023	BUY	$132.51 - $164.9 $530 - $659	4 Added 0.05%	8,395 $1.13 Million
Q1 2023 Apr 13, 2023	BUY	$144.61 - $166.54 $723 - $832	5 Added 0.06%	8,391 $1.34 Million
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $2,904 - $3,483	-21 Reduced 0.25%	8,386 $0
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $17,581 - $20,164	-131 Reduced 1.53%	8,407 $1.13 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $75,140 - $95,528	-546 Reduced 6.01%	8,538 $1.31 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $39,594 - $49,125	-300 Reduced 3.2%	9,084 $1.47 Million
Q4 2021 Jan 27, 2022	SELL	$107.43 - $135.93 $14,932 - $18,894	-139 Reduced 1.46%	9,384 $1.27 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $29,792 - $33,818	280 Added 3.03%	9,523 $1.03 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $526 - $586	5 Added 0.05%	9,243 $1.04 Million
Q1 2021 Apr 21, 2021	SELL	$102.3 - $112.62 $5,626 - $6,194	-55 Reduced 0.59%	9,238 $1 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $4,829 - $6,520	60 Added 0.65%	9,293 $996,000
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $67,280 - $90,031	917 Added 11.03%	9,233 $906,000
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $3,285 - $4,199	-50 Reduced 0.6%	8,316 $605,000
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $1,401 - $1,728	-18 Reduced 0.21%	8,366 $771,000
Q3 2018 Nov 05, 2018	BUY	$88.91 - $98.84 $266 - $296	3 Added 0.04%	8,384 $793,000
Q2 2018 Aug 21, 2018	BUY	$89.78 - $106.23 $5,835 - $6,904	65 Added 0.78%	8,381 $776,000
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $177,947 - $238,288	-1,934 Reduced 18.87%	8,316 $787,000
Q4 2017 Jan 29, 2018	BUY	$89.56 - $98.21 $179 - $196	2 Added 0.02%	10,250 $991,000
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $715,822 - $914,326	10,248	10,248 $911,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.

Account

Paragon Capital Management LTD Abb Vie Inc. Transaction History